[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368234-105":59,"doc-detail-368234-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","chemoresistance-mechanisms-to-5-fluorouracil-and-reversal-strategies-in-lung-and-breast-cancer","Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer","","Chemotherapy drug 5-Fluorouracil (5-FU) is widely used, but its clinical efficacy is constrained by chemoresistance. This study examines how lung and breast cancer cells develop resistance and evaluates potential reversal strategies using multiple 5-FU-resistant cell models. Differential cellular and molecular features of resistance are identified between cancer types. The work highlights immune-related processes and implicates NOTCH and WNT signaling, showing that WNT/β-catenin activation promotes resistance in lung cancer while pathway blockade re-sensitizes resistant cells to 5-FU.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemoresistance-mechanisms-to-5-fluorouracil-and-reversal-strategies-in-lung-and-breast-cancer/368234/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemoresistance-mechanisms-to-5-fluorouracil-and-reversal-strategies-in-lung-and-breast-cancer/368234.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is 5-Fluorouracil resistance a key limitation in cancer treatment?","Question",{"text":113,"@type":114},"The efficacy of 5-FU is limited because cancer cells can develop chemoresistance, reducing treatment effectiveness.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study model 5-FU resistance in lung and breast cancer cells?",{"text":118,"@type":114},"Multiple 5-FU-resistant cell line models were generated using traditional drug pulsing and specific gene knockout approaches.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does WNT/β-catenin signaling play in 5-FU resistance?",{"text":122,"@type":114},"WNT/β-catenin signaling is identified as a primary driver of 5-FU resistance in lung cancer cells; blocking this signaling re-sensitizes resistant cells to 5-FU.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368234,1790198335,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nChemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer  \nChunge Zhong1,2,3,4, Shengnan Wang1,2,3,4, Wen-Jie Jiang5, Zexu Li1,2,3,4,  \nXiaofeng Wang1,2,3,4, Shuangshuang Fan1,2,3,4, Jun Huang6, Hua-Jun Wu7,8,9, Ren Sheng1 & Teng Fei1,2,3,4􀀍  \nChemotherapy drug 5-Fluorouracil (5-FU) is a major treatment for many cancers; however, its efficacy is limited by chemoresistance. Here, we investigate the resistance mechanisms to 5-FU and reversal strategies in lung and breast cancer cells. Using multiple 5-FU-resistant lung cancer and breast cancer cell models, we reveal differential cellular and molecular features of 5-FU resistance between different cancer types. We further unravel the implications of immune-related processes, NOTCH and WNT signaling with 5-FU resistance. In lung cancer, the activation ofWNT/β-catenin signaling promotes the resistance and blocking this signaling re-sensitizes resistant cells to 5-FU treatment. Our study not only reveals differential features and mechanisms underlying 5-FU resistance across different cancers, but also suggests potential strategies against such resistance.  \nKeywords 5-Fluorouracil, Resistance, Cancer, WNT  \n5-Fluorouracil (5-FU) is a widely used chemotherapy drug in the treatment of various solid tumors such as colorectal cancer (CRC), head and neck, pancreas, breast, and ovarian cancers1. Some of the oral 5-FU pro-drugs (e.g., S-1, tegafur and capecitabine) were also approved to treat lung, liver, prostate, and cervical cancers2,3. Asan antimetabolite and an analogue of uracil, the fluoropyrimidine 5-FU exerts cytotoxic function by inhibition of the nucleotide synthetic enzyme thymidylate synthase (TS) and misincorporation of its metabolites into DNA and RNA, thereby resulting in aberrant nucleotide metabolism in the cells1.  \n5-FU has been proved as one of the most successful chemotherapy drugs for cancer treatment since its development in1950s. Nevertheless, drug resistance often happens for patients administrated with 5-FU or 5-FU-containing combo regimen. Several lines of mechanisms were proposed to mediate chemoresistance to 5-FU and other chemo drugs, including but not limited to increased drug efflux or decreased influx into the cells, altered drug metabolism and target, aberrant DNA repair machinery, changes of the cell cycle and survival pathways, epithelial-to-mesenchymal transition, cancer stem cell involvement, imbalanced redox status, and abnormal tumor microenvironment4–8. Specifically for 5-FU, the expression levels of nucleotide metabolizing enzymes such as TS and dihydropyrimidine dehydrogenase can determine the resistance status of tumors to 5-FU9. Moreover, several signaling pathways such as NOTCH and WNT pathways were reported to be involved in developing 5-FU resistance possibly via their regulation on cancer stem cells10–14. In addition, a bunch of microRNAs and long noncoding RNAs were identified to underlie 5-FU resistance through modulation of the above resistance-associated signaling pathways or cellular processes5. However, most of these mechanisms of 5-FU resistance were learned from studies conducted in CRC. Whether other types of cancer employ similar routes to develop 5-FU resistance remains largely unknown, and how to tackle such resistance in clinics is still challenging.  \n1Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China. 2Foshan Graduate School of Innovation, Northeastern University, Foshan 528311, China. 3National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China. 4Key Laboratory of Data Analytics and Optimization for Smart Industry (Northeastern University), Ministry of Education, Shenyang 110819, China.  \n5Peking University Third Hospital, B","cbCaijeba7Uf0yjh","https://ap.wps.com/l/cbCaijeba7Uf0yjh","pdf",6400786,"English","# Introduction\n# Results\n## Establishment of multiple 5-FU-resistant cells\n## Mechanistic insights into resistance pathways\n## Reversal strategies and therapeutic implications","[{\"question\":\"Why is 5-Fluorouracil resistance a key limitation in cancer treatment?\",\"answer\":\"The efficacy of 5-FU is limited because cancer cells can develop chemoresistance, reducing treatment effectiveness.\"},{\"question\":\"How did the study model 5-FU resistance in lung and breast cancer cells?\",\"answer\":\"Multiple 5-FU-resistant cell line models were generated using traditional drug pulsing and specific gene knockout approaches.\"},{\"question\":\"What role does WNT/β-catenin signaling play in 5-FU resistance?\",\"answer\":\"WNT/β-catenin signaling is identified as a primary driver of 5-FU resistance in lung cancer cells; blocking this signaling re-sensitizes resistant cells to 5-FU.\"}]","Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer | PDF",1790175794,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d20738edb0982a2b989526e8b83d848.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65f6e1f8561af883be402c830365a183.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a5b4438afe381769d6ff3af81914d24.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8c8316924dbf73945bb321d81cc4271.webp",980,1287]